|
59
|
196
|
5bxnN |
Yeast 20s proteasome beta2-g170a mutant in complex with bortezomib |
|
63
|
231
|
5l6bE |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
61
|
222
|
5laiL |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
65
|
200
|
5lf6K |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
66
|
233
|
5l66M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
68
|
211
|
5laiK |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
73
|
248
|
5lf0B |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
66
|
250
|
5l5hA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
61
|
222
|
5l5vL |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
58
|
226
|
5lajH |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
61
|
230
|
5lf0A |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
59
|
196
|
5l65N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
250
|
5lajA |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
75
|
212
|
5l55K |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
67
|
233
|
5l5oM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
242
|
5l63D |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
65
|
244
|
5lf3G |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
64
|
241
|
5l52G |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
57
|
204
|
5l54I |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
71
|
240
|
5l65C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
212
|
5lajK |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
63
|
231
|
5l52E |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
67
|
242
|
5l5vD |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
62
|
211
|
5l5oK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
69
|
243
|
5l5zF |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
68
|
233
|
5l69M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
58
|
204
|
5l5oI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
65
|
231
|
5l68E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
70
|
239
|
5lezF |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
67
|
242
|
5l5zD |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
240
|
5l67C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
59
|
226
|
5lttH |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
63
|
241
|
5l5dG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
59
|
195
|
5l66J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
55
|
196
|
5lf4J |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
50
|
174
|
5ji2A |
Hslu l199q in hsluv complex |
|
37
|
198
|
5a0qM |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
59
|
196
|
5bouN |
Yeast 20s proteasome in complex with a beta1 / beta2 specific non-peptidic sulfonamide ligand |
|
72
|
243
|
5jhrF |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 27 |
|
65
|
242
|
5jhsD |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 15 |
|
44
|
197
|
5a0qN |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
65
|
241
|
5jhrG |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 27 |
|
67
|
229
|
4z1lM |
Yeast 20s proteasome in complex with belactosin c derivative 3 |
|
70
|
233
|
5jhrM |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 27 |
|
27
|
187
|
5hftB |
Crystal structure of hpxw |
|
60
|
243
|
5a0qC |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
51
|
224
|
5a0qE |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
43
|
189
|
5a0qK |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
48
|
189
|
4zcgB |
Crystal structure of human ggt1 in complex with glutamate (with all atoms of glutamate) |
|
50
|
189
|
4zc6B |
Crystal structure of human ggt1 in complex with serine borate |
